{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T04:49:28Z","timestamp":1764305368992,"version":"3.44.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1053\/j.seminhematol.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:53:59Z","timestamp":1436403239000},"page":"321-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anemia of Central Origin"],"prefix":"10.1053","volume":"52","author":[{"given":"Kazusa","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"Williams hematology","author":"Kaushansky","key":"10.1053\/j.seminhematol.2015.07.002_bib1"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1179\/106698109790818223","article-title":"Is clinical gestalt good enough?","volume":"17","author":"Cook","year":"2009","journal-title":"J Manu Manipulat Ther"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","article-title":"How I treat acquired aplastic anemia","volume":"120","author":"Scheinberg","year":"2012","journal-title":"Blood"},{"issue":"18","key":"10.1053\/j.seminhematol.2015.07.002_bib4","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and the telomeropathies","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"issue":"24","key":"10.1053\/j.seminhematol.2015.07.002_bib5","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMra0903373","article-title":"Telomere diseases","volume":"361","author":"Calado","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib6","first-page":"96","article-title":"Bone marrow failure: a child is not just a small adult (but an adult can have a childhood disease)","author":"Alter","year":"2005","journal-title":"Hematol Educ Progr ASH"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","article-title":"Acquired pure red cell aplasia: updated review of treatment","volume":"142","author":"Sawada","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib9","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1515\/CCLM.2010.292","article-title":"Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis","volume":"48","author":"Piva","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib10","first-page":"327","article-title":"Erythropoiesis: normal and abnormal","volume":"4","author":"Hillman","year":"1967","journal-title":"Semin Hematol"},{"issue":"8 Pt 2","key":"10.1053\/j.seminhematol.2015.07.002_bib11","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/clinchem\/46.8.1277","article-title":"Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate","volume":"46","author":"Klee","year":"2000","journal-title":"Clin Chem"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/clinchem\/45.2.189","article-title":"Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies","volume":"45","author":"Holleland","year":"1999","journal-title":"Clin Chem"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0609.1977.tb02093.x","article-title":"Vitamin B12 metabolism in myelomatosis","volume":"18","author":"Hansen","year":"1977","journal-title":"Scand J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/jcp.19.1.17","article-title":"Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency","volume":"19","author":"Hoffbrand","year":"1966","journal-title":"J Clin Pathol"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.07.002_bib15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.159.12.1289","article-title":"Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician","volume":"159","author":"Snow","year":"1999","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib16","first-page":"19","article-title":"Cobalamin and folate deficiency: acquired and hereditary disorders in children","volume":"36","author":"Rosenblatt","year":"1999","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ajh.2830340205","article-title":"Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations","volume":"34","author":"Lindenbaum","year":"1990","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00043426-200108000-00015","article-title":"The Diamond Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia","volume":"23","author":"Vlachos","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-9343(85)90352-3","article-title":"Diamond-Blackfan syndrome in adult patients","volume":"78","author":"Balaban","year":"1985","journal-title":"Am J Med"},{"issue":"18","key":"10.1053\/j.seminhematol.2015.07.002_bib20","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2014-04-526301","article-title":"Marrow failure: a window into ribosome biology","volume":"124","author":"Ruggero","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2141.2008.07269.x","article-title":"Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference","volume":"142","author":"Vlachos","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.seminhematol.2011.02.003","article-title":"Untangling the phenotypic heterogeneity of Diamond Blackfan anemia","volume":"48","author":"Farrar","year":"2011","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.seminhematol.2013.09.002","article-title":"Genomic characterization of the inherited bone marrow failure syndromes","volume":"50","author":"Khincha","year":"2013","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib24","first-page":"530","article-title":"High-risk pregnancies in Diamond-Blackfan anemia: a survey of 64 pregnancies from the French and German registries","volume":"91","author":"Faivre","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.1988.tb06184.x","article-title":"Elevated red cell adenosine deaminase activity: a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases","volume":"68","author":"Glader","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0065-3101(22)00757-5","article-title":"Congenital hypoplastic anemia","volume":"22","author":"Diamond","year":"1976","journal-title":"Adv Pediatr"},{"issue":"19","key":"10.1053\/j.seminhematol.2015.07.002_bib27","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2010-02-251090","article-title":"How I treat Diamond-Blackfan anemia","volume":"116","author":"Vlachos","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00062752-200003000-00003","article-title":"Diamond-Blackfan anemia","volume":"7","author":"Willig","year":"2000","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/pbc.20642","article-title":"Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry","volume":"46","author":"Lipton","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V67.5.1411.1411","article-title":"Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia","volume":"67","author":"Saarinen","year":"1986","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib31","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI114274","article-title":"Immune response to B19 parvovirus and an antibody defect in persistent viral infection","volume":"84","author":"Kurtzman","year":"1989","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0889-8588(18)30662-2","article-title":"Diagnosis and management of red cell aplasia in children","volume":"1","author":"Glader","year":"1987","journal-title":"Hematol Oncol Clin N Am"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005792-198609000-00006","article-title":"Pure red-cell aplasia in patients with chronic lymphocytic leukemia","volume":"65","author":"Chikkappa","year":"1986","journal-title":"Medicine"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.07.002_bib34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23785","article-title":"Autoimmune cytopenias in chronic lymphocytic leukemia","volume":"89","author":"Visco","year":"2014","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0037-1963(03)00140-9","article-title":"Aplastic anemia and pure red cell aplasia associated with large granular lymphocyte leukemia","volume":"40","author":"Go","year":"2003","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajh.2830230211","article-title":"Autoreactive erythroid progenitor-T suppressor cells in the pure red cell aplasia associated with thymoma and panhypogammaglobulinemia","volume":"23","author":"Mangan","year":"1986","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and autoimmunity","volume":"8","author":"Shelly","year":"2011","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1034\/j.1399-0012.2000.140612.x","article-title":"Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature","volume":"14","author":"Geetha","year":"2000","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.07.002_bib40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-113-12-926","article-title":"Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS","volume":"113","author":"Frickhofen","year":"1990","journal-title":"Annals of internal medicine"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM199603073341004","article-title":"Autoantibodies against erythropoietin in a patient with pure red-cell aplasia","volume":"334","author":"Casadevall","year":"1996","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.07.002_bib42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib43","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/j.1875-9114.1996.tb03025.x","article-title":"Drug-induced pure red cell aplasia","volume":"16","author":"Thompson","year":"1996","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2141.1993.tb03359.x","article-title":"Pure red cell aplasia of pregnancy: a distinct clinical entity","volume":"85","author":"Baker","year":"1993","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib45","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib46","unstructured":"Hoffman R. Hematology: basic principles and practice. 5th ed. Philadelphia, PA: Churchill Livingstone\/Elsevier, 2009; xxvii:2523"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure red-cell aplasia of 10 years\u05f3 duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.07.002_bib48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/cis1046","article-title":"Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature","volume":"56","author":"Crabol","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood.V63.2.277.277","article-title":"Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients","volume":"63","author":"Clark","year":"1984","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0609.1997.tb00978.x","article-title":"Acquired pure red cell aplasia in Japan","volume":"59","author":"Mamiya","year":"1997","journal-title":"Eur J Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.11192","article-title":"Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group","volume":"92","author":"Sawada","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V98.2.483","article-title":"Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes","volume":"98","author":"Go","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib53","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.12871","article-title":"Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group","volume":"93","author":"Fujishima","year":"2008","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib54","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2141.2001.03039.x","article-title":"The effect of treatment with Campath-1H in patients with autoimmune cytopenias","volume":"114","author":"Willis","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2003.04609.x","article-title":"Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)","volume":"123","author":"Ru","year":"2003","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.2830230408","article-title":"Pure red cell aplasia: response to therapy with anti-thymocyte globulin","volume":"23","author":"Abkowitz","year":"1986","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.2830170412","article-title":"Successful treatment of chronic refractory pure red cell aplasia with antithymocyte globulin: correlation with in vitro erythroid culture studies","volume":"17","author":"Mangan","year":"1984","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib58","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V99.3.1092","article-title":"Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia","volume":"99","author":"Ghazal","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2141.2002.3317_3.x","article-title":"Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment","volume":"116","author":"Auner","year":"2002","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","article-title":"Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience","volume":"135","author":"Thompson","year":"2006","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0003-4975(10)63116-5","article-title":"The role of thymectomy in red cell aplasia","volume":"28","author":"Zeok","year":"1979","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group","volume":"93","author":"Hirokawa","year":"2008","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.07.002_bib63","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.bmt.1701785","article-title":"Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation","volume":"23","author":"Muller","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.10421","article-title":"Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation","volume":"74","author":"Tseng","year":"2003","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.07.002_bib65","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1704419","article-title":"Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation","volume":"33","author":"Musso","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib66","first-page":"76","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"2013","author":"Young","year":"2013","journal-title":"Hematol Educ Progr ASH"},{"issue":"19","key":"10.1053\/j.seminhematol.2015.07.002_bib67","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJM199105093241901","article-title":"Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group","volume":"324","author":"Frickhofen","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib68","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1182\/blood.V96.6.2049","article-title":"Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia","volume":"96","author":"Kojima","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.07.002_bib69","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058","article-title":"Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia","volume":"85","author":"Rosenfeld","year":"1995","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib70","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V95.6.1931","volume":"95","author":"Bacigalupo","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib71","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2002-01-0035","article-title":"Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia","volume":"100","author":"Sloand","year":"2002","journal-title":"Blood"},{"issue":"9431","key":"10.1053\/j.seminhematol.2015.07.002_bib72","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(04)16724-X","article-title":"In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing","volume":"364","author":"Risitano","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.07.002_bib73","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib74","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1182\/blood.V87.10.4149.bloodjournal87104149","article-title":"Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition","volume":"87","author":"Selleri","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib75","doi-asserted-by":"crossref","unstructured":"Solomou EE, Rezvani K, Mielke S, et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood. 2007;110(5):1603-1606.","DOI":"10.1182\/blood-2007-01-066258"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib76","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2011-11-390708","article-title":"Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2015.07.002_bib77","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","article-title":"STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients","volume":"122","author":"Jerez","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminhematol.2013.03.028","article-title":"Aplastic anemia: what have we learned from animal models and from the clinic","volume":"50","author":"Scheinberg","year":"2013","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib80","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s12185-010-0601-1","article-title":"Clinical course of non-severe aplastic anemia in adults","volume":"91","author":"Kwon","year":"2010","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib81","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.leu.2404119","article-title":"Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes","volume":"20","author":"Matsui","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib82","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2141.2002.03518.x","article-title":"Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy","volume":"117","author":"Ishiyama","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.2006.06105.x","article-title":"Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults","volume":"134","author":"Gupta","year":"2006","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.07.002_bib84","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/gcc.20793","article-title":"The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis","volume":"49","author":"Kim","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib85","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2014-10-607572","article-title":"Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia","volume":"125","author":"Dumitriu","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.07.002_bib86","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3324\/haematol.2009.017889","article-title":"Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine","volume":"95","author":"Scheinberg","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3324\/haematol.2008.001297","article-title":"Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes: clonal expansion of PIG-A-mutant hematopoietic cells in bone marrow failure","volume":"94","author":"Young","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib88","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.12661","article-title":"Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study","volume":"164","author":"Kulagin","year":"2014","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib89","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2005-06-2485","article-title":"Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia","volume":"107","author":"Sugimori","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib90","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2008.07450.x","article-title":"Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia","volume":"144","author":"Scheinberg","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib91","article-title":"transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities","volume":"2013","author":"Socie","year":"2013","journal-title":"Hematol Educ Progr ASH"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib92","first-page":"36","article-title":"Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation","volume":"2010","author":"Passweg","year":"2010","journal-title":"Hematol Educ Progr ASH"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0037-1963(00)90031-3","article-title":"Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy\u2014The European Group for Blood and Marrow Transplantation experience","volume":"37","author":"Bacigalupo","year":"2000","journal-title":"Semin Hematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.07.002_bib94","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3324\/haematol.2010.026682","article-title":"Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors","volume":"95","author":"Gupta","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib95","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood-2011-02-334953","article-title":"Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia","volume":"118","author":"Sanders","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib96","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V91.10.3637","article-title":"Long-term outcome after marrow transplantation for severe aplastic anemia","volume":"91","author":"Deeg","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib97","article-title":"Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib98","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","article-title":"Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.07.002_bib99","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbmt.2010.10.029","article-title":"Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia","volume":"17","author":"Chu","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib100","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib101","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2009.07842.x","article-title":"Guidelines for the diagnosis and management of aplastic anaemia","volume":"147","author":"Marsh","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib102","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.07.002_bib104","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","article-title":"Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug","volume":"123","author":"Desmond","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2141.1987.00289.x-i1","article-title":"Androstane therapy to treat aplastic anaemia in adults: an uncontrolled pilot study","volume":"65","author":"Gardner","year":"1987","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib106","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1986.tb01748.x","article-title":"Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias","volume":"36","year":"1986","journal-title":"Scand J Haematol"},{"issue":"18","key":"10.1053\/j.seminhematol.2015.07.002_bib107","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1182\/blood-2014-04-526293","article-title":"Stress and DNA repair biology of the Fanconi anemia pathway","volume":"124","author":"Longerich","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib108","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib109","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.seminhematol.2006.04.001","article-title":"Dyskeratosis congenita","volume":"43","author":"Vulliamy","year":"2006","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib110","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib112","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/bcmd.2001.0389","article-title":"Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita","volume":"27","author":"Vulliamy","year":"2001","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib113","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood.V91.10.3582","article-title":"Progressive telomere shortening in aplastic anemia","volume":"91","author":"Ball","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib114","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V97.4.895","article-title":"Telomere length in leukocyte subpopulations of patients with aplastic anemia","volume":"97","author":"Brummendorf","year":"2001","journal-title":"Blood"},{"issue":"9396","key":"10.1053\/j.seminhematol.2015.07.002_bib115","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","article-title":"Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA","volume":"362","author":"Fogarty","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib116","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood-2003-01-0335","article-title":"Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome","volume":"102","author":"Yamaguchi","year":"2003","journal-title":"Blood"},{"issue":"14","key":"10.1053\/j.seminhematol.2015.07.002_bib117","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa042980","article-title":"Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia","volume":"352","author":"Yamaguchi","year":"2005","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1053\/j.seminhematol.2015.07.002_bib118","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/hmg\/ddm111","article-title":"Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10","volume":"16","author":"Walne","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"23","key":"10.1053\/j.seminhematol.2015.07.002_bib119","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1073\/pnas.0800042105","article-title":"Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita","volume":"105","author":"Vulliamy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib121","doi-asserted-by":"crossref","first-page":"e10680","DOI":"10.1371\/journal.pone.0010680","article-title":"Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations","volume":"5","author":"Diaz de Leon","year":"2010","journal-title":"PloS One"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.07.002_bib122","doi-asserted-by":"crossref","first-page":"e7926","DOI":"10.1371\/journal.pone.0007926","article-title":"A spectrum of severe familial liver disorders associate with telomerase mutations","volume":"4","author":"Calado","year":"2009","journal-title":"PloS One"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib123","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1378\/chest.10-2865","article-title":"Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations","volume":"140","author":"Diaz de Leon","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib124","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH)","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat Protocols"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib125","article-title":"Reproducibility of telomere length assessment: an international collaborative study","author":"Martin-Ruiz","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib126","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.07.002_bib127","doi-asserted-by":"crossref","first-page":"e24383","DOI":"10.1371\/journal.pone.0024383","article-title":"Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations","volume":"6","author":"Vulliamy","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2014.114389","article-title":"Telomere length in inherited bone marrow failure syndromes","volume":"100","author":"Alter","year":"2015","journal-title":"Haematologica"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.07.002_bib129","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2013.35","article-title":"Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure","volume":"48","author":"Ayas","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib130","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.07.002_bib131","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib132","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V32.1.83.83","article-title":"Oxymetholone therapy in aplastic anemia","volume":"32","author":"Allen","year":"1968","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib133","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib134","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib135","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib136","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib137","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.07.002_bib138","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nature genetics"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib139","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3324\/haematol.2014.113456","article-title":"Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity","volume":"100","author":"Zhang","year":"2015","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2015.07.002_bib140","doi-asserted-by":"crossref","unstructured":"Townsley DM, Hsu A, Dumitriu B, Holland SM, Young NS. Regulatory mutations in GATA2 associated with aplastic anemia. ASH Annual Meeting Abstracts. 2012 November 16, 2012;120(21):3488.","DOI":"10.1182\/blood.V120.21.3488.3488"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib141","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00431-012-1715-7","article-title":"GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia","volume":"171","author":"Ishida","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib142","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2015.07.002_bib143","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","article-title":"New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"issue":"9464","key":"10.1053\/j.seminhematol.2015.07.002_bib144","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"7037","key":"10.1053\/j.seminhematol.2015.07.002_bib145","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"17","key":"10.1053\/j.seminhematol.2015.07.002_bib146","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib147","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-199405000-00003","article-title":"Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus","volume":"73","author":"Paquette","year":"1994","journal-title":"Medicine"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.07.002_bib148","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajh.10258","article-title":"Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome","volume":"72","author":"Pullarkat","year":"2003","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib149","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2796.1994.tb01052.x","article-title":"Sarcoidosis and agnogenic myeloid metaplasia","volume":"235","author":"Reich","year":"1994","journal-title":"J Intern Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib150","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0002-9343(77)90162-0","article-title":"Myelofibrosis and renal osteodystrophy","volume":"63","author":"Weinberg","year":"1977","journal-title":"Am J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib151","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198311000-00002","article-title":"The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival","volume":"62","author":"Varki","year":"1983","journal-title":"Medicine"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.07.002_bib152","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/340524","article-title":"Reversible myelofibrosis induced by tuberculosis","volume":"34","author":"Viallard","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1053\/j.seminhematol.2015.07.002_bib153","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood-2014-07-575373","article-title":"How I treat myelofibrosis","volume":"124","author":"Cervantes","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.07.002_bib154","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/ajh.23703","article-title":"Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Tefferi","year":"2014","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2141.1990.tb06375.x","article-title":"Pretransfused patients with severe aplastic anaemia exhibit high numbers of cytotoxic T lymphocyte precursors probably directed at non-HLA antigens","volume":"76","author":"Kaminski","year":"1990","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.07.002_bib156","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1182\/blood-2007-10-118372","article-title":"A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation","volume":"112","author":"Gajewski","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib157","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00062752-200211000-00010","article-title":"Leukoreduction of blood components","volume":"9","author":"Dzik","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib158","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199002013220507","article-title":"Transfusion-associated graft-versus-host disease","volume":"323","author":"Anderson","year":"1990","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.07.002_bib159","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2141.2012.09197.x","article-title":"Developments in the prevention of transfusion-associated graft-versus-host disease","volume":"158","author":"Fast","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.seminhematol.2007.04.010","article-title":"Hematopoietic growth factors in the treatment of acquired bone marrow failure states","volume":"44","author":"Marsh","year":"2007","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.07.002_bib161","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V89.3.739","article-title":"Iron-chelating therapy and the treatment of thalassemia","volume":"89","author":"Olivieri","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib162","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.V95.4.1229.004k32_1229_1236","article-title":"Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia","volume":"95","author":"Davis","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.07.002_bib163","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1542\/peds.2007-1824","article-title":"Oral iron chelators and the treatment of iron overload in pediatric patients with chronic anemia","volume":"121","author":"Vichinsky","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.07.002_bib164","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/03630260600642542","article-title":"Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*","volume":"30","author":"Kolnagou","year":"2006","journal-title":"Hemoglobin"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.07.002_bib165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","article-title":"Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major","volume":"331","author":"Brittenham","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.07.002_bib166","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631500058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631500058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:24:29Z","timestamp":1758522269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719631500058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":166,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S003719631500058X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.07.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anemia of Central Origin","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}